May 21, 2026 · Form 4 insider transaction
Blume-Jensen Peter sold 13,729 shares of Acrivon Therapeutics, Inc. at $1.79 per share, a transaction worth $24.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.; These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.